Duration and clearance of anal human papillomavirus (HPV) infection among women: The Hawaii HPV cohort study

Clinical Infectious Diseases

Volumn 48, Issue 5, 2009, Pages 536-546

  Shvetsov, Yurii B ^a   Hernandez, Brenda Y ^a   McDuffie, Katharine ^a   Wilkens, Lynne R ^a   Zhu, Xuemei ^a   Ning, Lily ^b   Killeen, Jeffrey ^d   Kamemoto, Lori ^c   Goodman, Marc T ^a  

^a UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF HAWAII   (United States)

^d KAPIOLANI MEDICAL CENTER FOR WOMEN AND CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; ANUS CANCER; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; DISEASE DURATION; FEMALE; FOLLOW UP; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MIXED INFECTION; PRIORITY JOURNAL; RISK FACTOR; UNITED STATES; VIRUS DETECTION; VIRUS INFECTION; AGED; ANAL CANAL; CLASSIFICATION; GENETICS; ISOLATION AND PURIFICATION; MIDDLE AGED; PAPILLOMA VIRUS; PATHOLOGY; PROCTITIS; TIME; UTERINE CERVIX; VIROLOGY;

ADULT; AGED; ANAL CANAL; CERVIX UTERI; COHORT STUDIES; FEMALE; HAWAII; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCTITIS; TIME FACTORS;

EID: 60549110122     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/596758     Document Type: Article

References (38)

1. American Cancer Society. Cancer facts and figures 2008. Atlanta, GA: American Cancer Society, 2008.
2. Moscicki AB, Hills NK, Shiboski S, et al. Risk factors for abnormal anal cytology in young heterosexual women. Cancer Epidemiol Biomarkers Prev 1999; 8:173-8.
3. Edgren G, Sparen P. Risk of anogenital cancer after diagnosis of cervical intraepithelial neoplasia: a prospective population-based study. Lancet Oncol 2007; 8:311-6.
4. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101:270-80.
5. Holly EA, Ralston ML, Darragh TM, Greenblatt RM, Jay N, Palefsky JM. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001; 93:843-9.
6. Frisch M, Glimelius B, van den Brule AJ, et al. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337:1350-8.
7. Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr 1998; 23:15-20.
8. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994; 83:205-11.
9. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 2007; 90:1-636.
10. Palefsky JM, Holly EA, Ralston ML, Da CM, Greenblatt RM. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 2001; 183:383-91.
11. Piketty C, Darragh TM, Da CM, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003; 138:453-9.
12. Frisch M, Melbye M, Moller H. Trends in incidence of anal cancer in Denmark. BMJ 1993; 306:419-22.
13. Brewster DH, Bhatti LA. Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer 2006; 95:87-90.
14. Chiao EY, Krown SE, Stier EA, Schrag D. A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 2005; 40:451-5.
15. Surveillance Research Program, National Cancer Institute. Surveillance epidemiology and end results: SEER*Stat software. Latest release: version 6.4.4. 2008. Available at: http://www.seer.cancer.gov/seerstat/. Accessed 24 April 2008.
16. Surveillance Epidemiology and End Results (SEER). SEER*Stat database: incidence - SEER 9 regs limited-use, Nov 2007 sub (1973-2005) - linked to county attributes - total U.S., 1969-2005 counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2008, based on the November 2007 submission.
17. Goodman MT, Shvetsov YB, McDuffie K, et al. Acquisition of anal human papillomavirus infection among women: the Hawaii HPV cohort study. J Infect Dis 2008; 197:957-66.
18. Hernandez BY, McDuffie K, Zhu X, et al. Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev 2005; 14:2550-6.
19. Goodman MT, Shvetsov YB, McDuffie K, et al. Hawaii cohort study of serum micronutrient concentrations and clearance of incident oncogenic human papillomavirus infection of the cervix. Cancer Res 2007; 67:5987-96.
20. Goodman MT, Shvetsov YB, McDuffie K, et al. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii HPV cohort study. Cancer Res 2008; 68:8813-24.
21. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38:357-61.
22. Gravitt PE, Schiffman M, Solomon D, Wheeler CM, Castle PE. A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUSLSIL triage study. Cancer Epidemiol Biomarkers Prev 2008; 17:1248-54.
23. Castle PE, Gravitt PE, Solomon D, Wheeler CM, Schiffman M. Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol 2008; 46:109-17.
24. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998; 36:3020-7.
25. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur HH. Classi-fication of papillomaviruses. Virology 2004; 324:17-27.
26. Muñoz N, Castellsagué X, de González AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24(Suppl 3):S1-10.
27. Dobson AJ, Kuulasmaa K, Eberle E, Scherer J. Confidence intervals for weighted sums of Poisson parameters. Stat Med 1991; 10:457-62.
28. Mickey RM, Greenland S. The impact of confounder selection criteria on effect estimation. Am J Epidemiol 1989; 129:125-37.
29. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81:515-26.
30. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989; 84:1074-8.
31. Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection. Vaccine 2006; 24(Suppl 1):S1-15.
32. Liaw KL, Hildesheim A, Burk RD, et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001; 183:8-15.
33. Rousseau MC, Pereira JS, Prado JC, Villa LL, Rohan TE, Franco EL. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. J Infect Dis 2001; 184:1508-17.
34. Koshiol JE, Schroeder JC, Jamieson DJ, et al. Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer 2006; 119:1623-9.
35. Molano M, Van den Brule A, Plummer M, et al. Determinants of clearance of human papillomavirus infections in Colombian women with normal cytology: a population-based, 5-year follow-up study. Am J Epidemiol 2003; 158:486-94.
36. Daling JR, Sherman KJ, Hislop TG, et al. Cigarette smoking and the risk of anogenital cancer. Am J Epidemiol 1992; 135:180-9.
37. Mayrand MH, Duarte-Franco E, Rodrigues I, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007; 357:1579-88.
38. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370:890-907.